Medfort Hospitals Pvt. Ltd (Medfort), India’s leading healthcare delivery organization focused on eye care and diabetes, today announced the merger with Maxivision Eye Hospitals (Maxivision), a renowned eye care chain headquartered in Hyderabad, Andhra Pradesh. This merger will result in: Dr. Kasu Prasad Reddy, one of the best Refractive Opthalmic surgeons in the world and founder of Maxivision Eye Hospitals, spearheading the combined entity as a Co-Chairman and heading all eye-care initiatives of the joint entity, Medfort Maxivision Group Medfort-Maxivision emerging as a 12 eye-hospital network, with presence in 6 cities, namely, Hyderabad, Chennai, Delhi NCR, Vizag, Vijayawada and UAE All the Eyecare activities of Medfort Group being rebranded as Maxivision Eyecare and Maxivision Lasik Suites across India Housing the best-in-class cataract and retina units. The joint entity will house refractive Lasik Suites combining Supracor and Intracor to provide Lasik treatment, including presbyopic lasik treatment for all class of patients Commenting on this merger Dr. G. S. K. Velu, Chairman, Medfort Hospitals said, “Medfort has seized the opportunity provided by the lacuna in synergized, high quality Vision Care and Diabetes Care to emerge as the largest day care chain in the country.” Dr. Velu said that Medfort hopes to expand Maxivision’s network to include 50 hospitals across 20 cities within the next 12 months. Dr. Usha Sriram, leading endocrinologist and Medical Director of Medfort, welcomed Dr. K. P. Reddy on board and expressed her delight in partnering with a dynamic organization like Maxivision. “As significant cross referrals between diabetes care and eye-care is a reality, Medfort is committed to providing comprehensive care for both,” she said. Maxivision, a technological leader in Refractive Eyecare, has many firsts to its credit, including the first site to house the Asia’s First Femtosecond Cataract Lasik Suite in Hyderabad. On this occasion, Dr. Kasu Prasad Reddy, Chairman and Managing Director, Maxivision said, “Medfort shares the same mission as that of Maxivision. We will continue to be the technology and clinical excellence leader in eye care services, and clinical research in to eye diseases and vision-threatening conditions. Our aim is to strengthen people and processes to be able to provide passionate and high quality services to patients across multiple locations in India and globally. Technological superiority, best in class Ophthalmologists, and friendly ambience and customer services resulting in best clinical outcome will be the focus of all activities within Maxivision Eyecare and Lasik Suite initiatives”. The present state reveals that around 10 percent of Indian population suffers from some form of visual impairment, which means more than 12 crore Indians need attention by ophthalmologists. 85 percent of this population suffers cataract and refractive errors. The opportunity for cataract services in the top 35 Indian cities itself is worth more than Rs 3000 crore. Medfort expects this market to continue remaining attractive, since the surgical rate lags the rate of incidence in the nation and there is a significant cataract back-log which awaits clearance. The refractive error opportunity is equally large. Gaurav Malhotra, Chief utive Officer, Medfort Hospitals said, “The current condition of visual impairment amongst Indian population sites an alarming situation and hence there is a need to bring in our expertise here. With the addition of Maxivision’s strengths like technology, doctors, processes and passion, we expect to grow our eye care business significantly in the next two years. We plan to set up another 50 Diabetes and eye-care centres of excellence in AP, Punjab, Haryana, Maharashtra, Tamil Nadu, Middle-East and Karnataka”. Dr. Reddy also announced the entry of Maxivision into Chennai. Maxivision’s Chennai facility will be the first in India to house the best in class comprehensive Eyecare, endocrine & Diabetic Care under one roof. A 24×7 Customer Care number for patients will also be made available to reach out to doctors and para medical staff for immediate help.